Senior insider sale
SAREPTA THERAPEUTICS, INC. — senior position signals high conviction
$1.59M
15K shares
What this filing means
WIGZELL HANS LENNART RUDOLF plans to sell 15K shares of SAREPTA THERAPEUTICS, INC. valued at approximately $1.59M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/4/2023ACC: 0001972362-23-000578
Director
Since Nov 2018
15K
Shares to sell
$1.59M
Approx. market value
15K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
Compensation
8/4/2023
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/4/2023 | STOCK OPTION EXERCISE Compensation | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
15K
Market value
$1.59M
8/4/2023
Total
Units
15K
Value
$1.59M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/4/2023 | 15K | $1.59M | NASDAQ | Planned |
| Total | 15K | $1.59M | ||